|
When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment. |
02-Sep-2010 - CMO Vetter Pharma has set up a US sales office in Skokie, Illinois to attract customers in growing Midwest drug industry hub.
02-Sep-2010 - Accenture and ICRI have partnered to jointly develop a pharmacovigilance and clinical research programme for the Indian market.
02-Sep-2010 - Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.
01-Sep-2010 - Retention strategies, trial site evaluations and dedicated budgets should be used to recruit patients to, and keep them in, clinical trials, according to research.
31-Aug-2010 - Forming a strategic partnership with a CRO is one of the key steps to boosting patient recruitment, according to a report.
26-Aug-2010 - CRO Argint is to provide Brookwood clinical research training courses in Eastern Europe to meet demand created by trial growth in the region.
25-Aug-2010 - The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.
25-Aug-2010 - Questions about the ethics and scientific validity of trials conducted under the Pediatric Exclusivity Provision have been raised after researchers found many studies used sites outside the US.
19-Aug-2010 - ClinTec International is to expand in India and Asia Pacific having received investment from Elephant Capital.
19-Aug-2010 - Clearstone Central Laboratories is partnering with LabCorp to give clients access to more biomarker and esoteric services.
18-Aug-2010 - Encorium cut its operating loss to $775,000 in the second quarter despite posting a 17 per cent drop in total revenue.
18-Aug-2010 - TRI has been awarded a contract with the US NIAID to provide clinical, regulatory and operational support for domestic and overseas HIV research.
17-Aug-2010 - Drug industry focus on clinical data quality, cost and speed is key driver for recent growth of Hungarian trials business says patient recruitment specialist Synexus.
17-Aug-2010 - Patheon is partnering with TraceLink to increase manufacturing efficiencies through closer integration and collaboration with clients.
16-Aug-2010 - Clondalkin aims to expand its pharmaceutical cartoning and labelling business with reorganised operations in Ireland and Poland.
16-Aug-2010 - Warnex says demand for contract analysis services increase in Q2 thanks to expansion in diagnostics market and forecasts growth opportunities in India.
16-Aug-2010 - Pre-clinical ADME contractor Cyprotex upbeat about 2010 despite drop in profit, citing new US opportunities post-Apredica acquisition.
11-Aug-2010 - Outsourcing-pharma presents a round-up of recent developments in the contract research sector, with news from Quintiles, Bioclinica and Cyprotex.
11-Aug-2010 - BioServe and NGC Medical SpA have partnered to form a company offering preclinical molecular services and biospecimens to European researchers.
10-Aug-2010 - Parexel recorded growth in the fourth quarter, contributing to a 10 per cent increase in full year GAAP operating income and an improved backlog.
09-Aug-2010 - Contract research organization (CRO) Lambda Therapeutic Research has acquired Biovail’s contract research division.
09-Aug-2010 - Quintiles says it is confident that all proper procedures were followed during a 2006 study of Theravance’s antibiotic telvancin being audited by Indian drug regulators.
09-Aug-2010 - Kendle posted a 90 per cent drop in operating income, caused by lower revenues and continued investments, but was buoyed by pipeline growth.
05-Aug-2010 - AMRI recorded a $6.0m (€4.6m) operating loss in the second quarter as restructuring charges and the lack of milestone payments offset contract service gains.
05-Aug-2010 - Norwich Pharmaceuticals has added development-stage drug production to its offering with new dedicated non-GMP capacity at its New York plant.